about
New and investigational treatments in cystic fibrosis.Elastin-like polypeptides: Therapeutic applications for an emerging class of nanomedicines.Asymmetric 4-aryl-1,4-dihydropyridines potentiate mutant cystic fibrosis transmembrane conductance regulator (CFTR).Synthesis and properties of molecular probes for the rescue site on mutant cystic fibrosis transmembrane conductance regulator.Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.Preventive but not late amiloride therapy reduces morbidity and mortality of lung disease in betaENaC-overexpressing mice.
P2860
description
im Mai 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2007
@uk
name
Emerging drug treatments for cystic fibrosis
@en
Emerging drug treatments for cystic fibrosis
@nl
type
label
Emerging drug treatments for cystic fibrosis
@en
Emerging drug treatments for cystic fibrosis
@nl
prefLabel
Emerging drug treatments for cystic fibrosis
@en
Emerging drug treatments for cystic fibrosis
@nl
P2860
P1476
Emerging drug treatments for cystic fibrosis
@en
P2093
Pamela L Zeitlin
P2860
P304
P356
10.1517/14728214.12.2.329
P407
P577
2007-05-01T00:00:00Z